Novartis Venture Fund logo
Novartis Venture Fund logo

Novartis Venture Fund

nvfund.com
nvfund.com · HQ: Basel, Switzerland · 1-10 employees · Founded 1996
HQ: Basel, Switzerland · 1-10 employees · Founded 1996
Biotechnology
Venture Capital
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Investor profile

Venture capital
Investments
31
19 of them startups
Hiring now
3
593 open roles
Rounds in 12 months
7
$446M raised
Exits
5
Focusshare of its companies
Health Care 79%Biotechnology 29%Artificial Intelligence 14%Cybersecurity 7%
Where its companies are
United States 16%United Kingdom 10%Switzerland 6%Germany 3%France 3%
Stage of its companies
Series B 45%Series A 36%Series C and later 18%
Its companies, the freshest money firstAll 31 investments
Hyku BiosciencesVenture round $8.6M · 3 mo ago Fore BiotherapeuticsSeries D $67.4M · 3 mo ago Sidewinder TherapeuticsSeries B $137M · 6 mo ago NRG TherapeuticsVenture round · 8 mo ago EpiBiologicsSeries B $107M · 9 mo ago Mediar TherapeuticsSeries B $76M · 9 mo ago FoRx TherapeuticsSeries A $50M · 10 mo ago EpsilogenVenture round · 14 mo ago SpliceBioSeries B $135M · 16 mo ago ONL TherapeuticsVenture round $60M · 2 yr ago Averna TherapeuticsVenture round $85M · 2 yr ago AstronautxSeries A $61M · 3 yr ago
593 open roles at 3 of its companies
Hiring fastestroles opened in 30 days
Novartis342 new roles in 30 days Catalym3 new roles in 30 days
Co-investorscompanies they hold together
Ysios Capital 4 shared OrbiMed 4 shared BioGeneration Ventures 3 shared M Ventures 3 shared Epidarex Capital 2 shared RA Capital Management 2 shared Pontifax 2 shared Sofinnova Partners 2 shared GV 2 shared NEA 2 shared
Similar investorstheir companies share markets and countries
Sofinnova Investments Jeito Capital venBio Partners RA Capital Management Foresite Capital Aisling Capital EcoR1 Capital Taiho Ventures
Sources: its portfolio page, read Oct 3

Overview

Novartis Venture Fund is the corporate venture capital fund of pharmaceutical group Novartis, focused on life sciences. It invests in biotechnology and biopharmaceutical companies developing therapeutics for unmet patient needs, from company creation and early rounds through later-stage financings in the United States and Europe. The fund was established in 1996 and is based in Basel, Switzerland, operating as an evergreen investor with independent decision making.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Basel Switzerland
HQ
1-10 est. staff